For the first time in the consumer genomics industry, AncestryDNA will provide customers with a list of probable ancestors based solely on their microarray data.
Scheller discussed with GenomeWeb why he joined 23andMe after leaving Genentech and his plans for the new therapeutics division.
The consumer genomics firm has created a therapeutics group headed up by former Genentech executive Richard Scheller.
The value of consumer genomics services is increasing as customers seek to discover new cousins and adoptees track down their biological birth parents.
Genentech and 23andMe aim to advance Parkinson's drug research by sequencing the largest number of people to date.
Consumer genomics companies have seen their databases swell with hundreds of thousands of new samples, introduced diverse offerings, and adjusted to new competitors.
Toshiba has the exclusive right to provide genotyping services on the Japonica Array to Japanese universities, hospitals, pharmaceutical companies, and other research organizations.
The FDA's regulation of lab tests and devices used in clincial investigations is impacting federally funded study protocols involving advanced sequencing tests.
For the time being, the company doesn't expect to run into regulatory trouble in the UK.
The Clinical Genome Resource has launched GenomeConnect, an online portal for patients to voluntarily contribute their de-identified genotypic and phenotypic information to publicly available genomic databases.
Retraction Watch reports that a paper was pulled because it refers to a gene that doesn't exist in mice.
Researchers were able to generate fertilized northern white rhinoceros eggs, according to Mashable.
Former Orig3n employees raise concerns about its testing at Bloomberg Businessweek.
In PLOS this week: microRNA expression changes in hepatocellular carcinoma, real-time PCR-based approach for diagnosing schistosomiasis, and more.